Qube Research & Technologies LTD Calliditas Therapeutics Ab Transaction History

Qube Research & Technologies LTD

2 transactions

Quarter	Operation	Price Per share	shares change	shares Held	SEC Form
Q2 2024 Aug 14, 2024	SELL	$17.65 - $41.41 $970 - $2,277	-55 Reduced 76.39%	17 $0
Q3 2023 Nov 13, 2023	BUY	$15.68 - $20.38 $1,128 - $1,467	72 New	72 $1,000

4.17K

Ticker CALT
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 26,624,800
Market Cap $1.06B
Description
Calliditas Therapeutics AB (publ), a clinical-stage biopharmaceutical company, focused on identifying, developing, and commercializing pharmaceuticals products for treatments in orphan indications with initial focus on renal and hepatic diseases. It offers Nefecon, an oral formulation of budesonide that is an immunosuppressant for the treatment ...

Get notified when there are updates to the investment portfolio of Qube Research & Technologies LTD, based on Form 13F filings with the SEC.

Stay updated on Qube Research & Technologies LTD with notifications on news.